93 related articles for article (PubMed ID: 3791142)
1. A phase I trial of continuous infusion cisplatin.
Posner MR; Ferrari L; Belliveau JF; Cummings FJ; Wiemann MC; O'Rourke A; Weitberg AB; Calabresi P
Cancer; 1987 Jan; 59(1):15-8. PubMed ID: 3791142
[TBL] [Abstract][Full Text] [Related]
2. Phase I study of continuous-infusion cisplatin.
Posner MR; Skarin AT; Clark J; Ervin TJ
Cancer Treat Rep; 1986 Jul; 70(7):847-50. PubMed ID: 3013401
[TBL] [Abstract][Full Text] [Related]
3. Phase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: a Cancer and LeukemiaGroup B study.
Lilenbaum RC; Miller AA; Batist G; Bernard S; Hollis DR; Rosner GL; Egorin MJ; Schilsky RL; Ratain MJ
J Clin Oncol; 1998 Oct; 16(10):3302-9. PubMed ID: 9779705
[TBL] [Abstract][Full Text] [Related]
4. High-dose cisplatin in patients with advanced malignancies.
Blumenreich MS; Woodcock TM; Jones M; Richman SP; Gentile PS; Kubota TT; Allegra JC
Cancer; 1985 Mar; 55(5):1118-22. PubMed ID: 4038468
[TBL] [Abstract][Full Text] [Related]
5. Phase I trial of escalating doses of cisplatin in hypertonic saline.
Bajorin D; Bosl GJ; Fein R
J Clin Oncol; 1987 Oct; 5(10):1589-93. PubMed ID: 3309197
[TBL] [Abstract][Full Text] [Related]
6. A phase I trial of 5-day continuous infusion cisplatin and interferon alpha.
Gosland MP; Goodin S; Yokel RA; Smith M; John WJ
Cancer Chemother Pharmacol; 1995; 37(1-2):39-46. PubMed ID: 7497595
[TBL] [Abstract][Full Text] [Related]
7. Continuous infusion carboplatin on a 21-day schedule: a phase I and pharmacokinetic study.
Smit EF; Willemse PH; Sleijfer DT; Uges DR; Postmus PE; Meijer S; Terheggen PM; Mulder NH; de Vries EG
J Clin Oncol; 1991 Jan; 9(1):100-10. PubMed ID: 1985158
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetic evaluation of continuous infusion cisplatin].
Hiura M; Takenawa J; Ryoji O; Taki Y; Hyashi T; Kiriyama T
Hinyokika Kiyo; 1989 Jun; 35(6):955-61. PubMed ID: 2801396
[TBL] [Abstract][Full Text] [Related]
9. Activity of JM9 in advanced ovarian cancer: a phase I-II trial.
Bramwell VH; Crowther D; O'Malley S; Swindell R; Johnson R; Cooper EH; Thatcher N; Howell A
Cancer Treat Rep; 1985 Apr; 69(4):409-16. PubMed ID: 3995511
[TBL] [Abstract][Full Text] [Related]
10. Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer.
Hansen RM; Ryan L; Anderson T; Krzywda B; Quebbeman E; Benson A; Haller DG; Tormey DC
J Natl Cancer Inst; 1996 May; 88(10):668-74. PubMed ID: 8627643
[TBL] [Abstract][Full Text] [Related]
11. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
12. The use of probenecid as a chemoprotector against cisplatin nephrotoxicity.
Jacobs C; Kaubisch S; Halsey J; Lum BL; Gosland M; Coleman CN; Sikic BI
Cancer; 1991 Mar; 67(6):1518-24. PubMed ID: 1848154
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretion.
Belliveau JF; Posner MR; Ferrari L; Crabtree GW; Cummings FJ; Wiemann MC; O'Leary GP; Griffin H; Phaneuf MA; O'Rourke A
Cancer Treat Rep; 1986 Oct; 70(10):1215-7. PubMed ID: 3756943
[TBL] [Abstract][Full Text] [Related]
14. High-dose cisplatin with sodium thiosulfate protection.
Pfeifle CE; Howell SB; Felthouse RD; Woliver TB; Andrews PA; Markman M; Murphy MP
J Clin Oncol; 1985 Feb; 3(2):237-44. PubMed ID: 4038510
[TBL] [Abstract][Full Text] [Related]
15. Phase I study of cis-diamminedichloroplatinum(II) administered as a constant 5-day infusion.
Lokich JJ
Cancer Treat Rep; 1980; 64(8-9):905-8. PubMed ID: 6256073
[TBL] [Abstract][Full Text] [Related]
16. [Pilot phase II study of 5-day continuous infusion of cisplatin in treatment of non-small cell lung cancer].
Saito Y; Mori K; Yokoi K; Tominaga K; Miyazawa N
Gan To Kagaku Ryoho; 1989 May; 16(5):2081-6. PubMed ID: 2543330
[TBL] [Abstract][Full Text] [Related]
17. A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies.
Britten CD; Rowinsky EK; Baker SD; Agarwala SS; Eckardt JR; Barrington R; Diab SG; Hammond LA; Johnson T; Villalona-Calero M; Fraass U; Statkevich P; Von Hoff DD; Eckhardt SG
Clin Cancer Res; 1999 Jul; 5(7):1629-37. PubMed ID: 10430061
[TBL] [Abstract][Full Text] [Related]
18. [Phase I/II clinical trial of weekly administration of docetaxel plus cisplatin for advanced non-small cell lung cancer].
Li JL; Zhang XR; Liu JW; Chen ZY; Lin YC; Wang YD; Chen Q; Nan KJ; Song SP; Han FC; Zhu YZ; Li LY; Zheng YH; Chu DT
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):309-12. PubMed ID: 16875636
[TBL] [Abstract][Full Text] [Related]
19. Phase-I study of protracted infusion of cisplatin.
Lokich JJ; Zipoli TE
Cancer Drug Deliv; 1984; 1(3):247-50. PubMed ID: 6544124
[TBL] [Abstract][Full Text] [Related]
20. A phase I study of chronic daily dosing of oral etoposide in combination with cisplatin for patients with advanced cancer.
Fukuoka M; Masuda N; Negoro S; Takada M; Kudoh S; Kusunoki Y; Matsui K; Takifuji N; Tachikawa A; Kawahara M
Cancer; 1991 Jul; 68(2):284-8. PubMed ID: 2070326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
